Market research
ELX.AU Nova Eye Medical Limited
AU AUD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 102M
- P/E ratio
- 2.86
- Analyst target
- 1.69
- Dividend yield
- 0.0%
- Beta
- 0.62
Profile
Company facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- AU0000094252
- Market cap
- 102M
- P/E ratio
- 2.86
- Analyst target
- 1.69
- Dividend yield
- 0.0%
- Beta
- 0.62
About
About Nova Eye Medical Limited
Nova Eye Medical Limited designs, manufactures, distributes, and services medical equipment and devices to diagnose and treat eye diseases. The company offers iTrack, a surgical system for the reduction of intraocular pressure (IOP) in adult patients with openangle glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. It operates in Australia, the United States, Europe, the Middle East, Japan, rest of Asia, South America, and internationally. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the ELX.AU discussion.
5 years, 5 months ago
Nova Eye Medical Limited is currently in a long term uptrend where the price is trading 12.5% above its 200 day moving average.
From a valuation standpoint, the stock is 98.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.0.
Based on the above factors, Nova Eye Medical Limited gets an overall score of 2/5.